Moreover, in line with the gene expression profiles in mice, publicly available gene expression datasets of liver biopsies of MASLD/MASH patients show high similarities with the PPARα KO transcriptome signature, which reveals loss of PPARα function in these patients. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.